ask="11.250"
ask_size="900"
average_daily_volume="12635"
bid="5.150"
bid_size="100"
book_value="2.911"
change="-0.171"
change_from_200_day_moving_average="0.080"
change_from_50_day_moving_average="1.338"
change_from_52_week_high="-3.981"
change_From_52_week_low="2.749"
change_in_percent="-1.681%"
close="9.999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.643"
ebitda="0.00"
eps_estimate_current_year="-2.120"
eps_estimate_next_quarter="-0.540"
eps_estimate_next_year="-1.850"
ex_dividend_date="N/A"
float_shares="3362000"
high="10.169"
high_52_weeks="13.980"
last_trade_date="1/11/2017"
last_trade_price="9.999"
last_trade_size="200"
last_trade_time="3:19pm"
low="9.999"
low_52_weeks="7.250"
market_capitalization="92.69M"
moving_average_200_day="9.919"
moving_average_50_day="8.661"
name="Gemphire Therapeutics Inc."
notes="N/A"
one_year_target_price="19.750"
open="10.131"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+0.806%"
percent_change_from_50_day_moving_average="+15.450%"
percent_change_from_52_week_high="-28.476%"
percent_change_from_52_week_low="+37.917%"
previous_close="10.170"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.494"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9270000"
short_ratio="0.580"
stock_exchange="NGM"
symbol="GEMP"
volume="1737"
weeks_range_52="7.250 - 13.980"
